Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Medmix AGCHIX:MEDXZ +1.97%66 Days Payable is 63.87 as of Jun. 2026, which is 19% above its 10-year median of 53.56. GuruFocus rates CHIX:MEDXZ with a GF Score™ of 66/100 and a GF Value™ of CHF9.05 (Fairly Valued). The stock has 6 warning signs investors should review. Among 2,994 Industrial Products companies, Medmix AG ranks worse than 59.92% on this metric.
Medmix AG's average Accounts Payable for the
six
months ended in Jun. 2026 was CHF46.7 Mil. Medmix AG's Cost of Goods Sold for the
six
months ended in Jun. 2026 was CHF133.3 Mil.
Hence, Medmix AG's Days Payable for the
six
months ended in Jun. 2026 was 63.87.
The historical rank and industry rank for Medmix AG's Days Payable or its related term are showing as below:
CHIX:MEDXz'
s Days Payable Range Over the Past 10 Years
Min: 46.86 Med: 53.56 Max: 62.26
Current: 62.26
During the past 8 years, Medmix AG's highest Days Payable was 62.26. The lowest was 46.86. And the median was 53.56.
CHIX:MEDXz's Days Payable is ranked worse than 59.92% of 2994
companies
in the Industrial Products industry
Industry Median: 78.065
vs CHIX:MEDXz: 62.26
Medmix AG's Days Payable
increased
from Jun. 2025 (55.94) to Jun. 2026 (63.87).
It may suggest that Medmix AGdelayed paying its suppliers.
The historical data trend for Medmix AG's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:MEDXZ vs GEV, ETN, PH: Days Payable Comparison
For the Specialty Industrial Machinery subindustry, Medmix AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Medmix AG Days Payable vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, Medmix AG's Days Payable distribution charts can be found below:
* The bar in red indicates where Medmix AG's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Medmix AG's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medmix AG (CHIX:MEDXZ) has a Days Payable of 63.87 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medmix AG and its competitors. This is 19% above median its historical median of 53.56. Over the past decade, Medmix AG's Days Payable has ranged from 46.86 to 62.26. According to the industry distribution chart, Medmix AG ranks #1794 out of 2994 companies in the Industrial Products industry, placing it in the top 59.9%.
Is Medmix AG's Days Payable too high?
Medmix AG's current Days Payable of 63.87 is 19% above median its 10-year median of 53.56. Over the past 10 years, this metric has ranged from a low of 46.86 to a high of 62.26. The Industrial Products industry median Days Payable is 78.07. Medmix AG's value of 63.87 is 18.2% below this industry median. Based on the distribution chart, Medmix AG ranks #1794 out of 2994 companies in the Industrial Products industry, which is below the industry midpoint. Overall, Medmix AG has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medmix AG's Days Payable compare to GEV and ETN?
According to the Industrial Products industry distribution chart, Medmix AG ranks #1794 out of 2994 companies for Days Payable. This places Medmix AG in the lower half of its industry. The industry median Days Payable is 78.07. Medmix AG's value of 63.87 is 18.2% below this benchmark. Historically, Medmix AG's own Days Payable has ranged from 46.86 to 62.26 over the past decade. While the company's 10-year median is 53.56 vs. the industry median of 78.07, Medmix AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for an Industrial Products company?
The median Days Payable among Industrial Products companies is 78.07, based on 2,994 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Medmix AG's current Days Payable of 63.87 is 18.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Medmix AG and its competitors. For the Industrial Products industry, the median Days Payable is 78.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medmix AG's current Days Payable is 63.87, which is 19% above median its own 10-year median of 53.56. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medmix AG stock overvalued right now?
Based on GuruFocus' analysis, Medmix AG (CHIX:MEDXZ) is currently considered Fairly Valued. The stock's GF Value™ is CHF9.05, compared to a current price of CHF8.54 — trading 5.7% below its estimated fair value. The current Days Payable is 63.87, which is 19% above median its 10-year median of 53.56 and 18.2% below the Industrial Products industry median of 78.07. Medmix AG's overall GF Score™ is 66/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Medmix AG (CHIX:MEDXZ), the current Days Payable is 63.87 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medmix AG (CHIX:MEDXZ) Overvalued in 2026?
Based on GuruFocus' analysis, Medmix AG stock appears to be undervalued.
The current stock price of CHF8.54 is trading 5.7% below its estimated GF Value™ of CHF9.05.
GuruFocus considers Medmix AG to be Fairly Valued.
Key valuation signals for CHIX:MEDXZ:
Days Payable: 63.87 (19% above median its 10-year median of 53.56)
GF Value™: CHF9.05 vs. price of CHF8.54 (5.7% below fair value)
Industry Position: 18.2% below the Industrial Products median (#1794 of 2994)
No single metric tells the full story. See the CHIX:MEDXZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medmix AG designs and produces high-precision delivery devices for the healthcare, consumer and industrial segments. Its segments are Healthcare, Consumer & Industrial, and Others. The Healthcare segment focuses on delivery devices for the drug delivery, surgery, and dental markets, including injection pens for subcutaneous drug delivery, surgical delivery devices, and mixing and delivery systems for the dental consumable industry. The Consumer & Industrial segment focuses on delivery devices used for industrial applications such as adhesives in construction, electronics, automotive, and aerospace, as well as consumer markets such as beauty and microbrush applications. The company operates in Europe, the Middle East and Africa, the Americas, and Asia-Pacific.
66GF Score
Get the complete analysis for CHIX:MEDXZ
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:MEDXZ has been successfully added to your 
